Community-based provision of direct-acting antiviral therapy for hepatitis C: Study protocol and challenges of a randomized controlled trial

QR Code

Community-based provision of direct-acting antiviral therapy for hepatitis C: Study protocol and challenges of a randomized controlled trial

Background: To achieve the World Health Organization hepatitis C virus (HCV) elimination targets, it is essential to increase access to treatment. Direct-acting antiviral (DAA) treatment can be provided in primary healthcare services (PHCS), improving accessibility, and, potentially, retention in ca...

Full description

Bibliographic Details
Main Authors:	Wade, A., Doyle, J., Gane, E., Stedman, C., Draper, B., Iser, D., Roberts, S., Kemp, W., Petrie, D., Scott, N., Higgs, Peter, Agius, P., Roney, J., Stothers, L., Thompson, A., Hellard, M.
Format:	Journal Article
Published:	BioMed Central 2018
Online Access:	http://hdl.handle.net/20.500.11937/69783

Similar Items

Improving hepatitis C direct-acting antiviral access and uptake: A role for patient-reported outcomes and lived experience
by: Goutzamanis, S., et al.
Published: (2019)

“I'm obviously not dying so it's not something I need to sort out today”: Considering hepatitis C treatment in the era of direct acting antivirals
by: Wright, C., et al.
Published: (2018)

Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia
by: Hellard, M., et al.
Published: (2012)

Outcomes after successful direct acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
by: Cheung, Michelle C.M., et al.
Published: (2016)

Cohort study of the impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
by: Foster, Graham R., et al.
Published: (2016)

Establishing the cascade of care for hepatitis C in England-benchmarking to monitor impact of direct acting antivirals
by: Simmons, Ruth, et al.
Published: (2017)

Reversal of end-stage renal failure using direct-acting antiviral agents for chronic hepatitis C
by: Mitchell, T., et al.
Published: (2016)

Experiences of liver health related uncertainty and self-reported stress among people who inject drugs living with hepatitis C virus: A qualitative study
by: Goutzamanis, S., et al.
Published: (2018)

Field engagement further facilitates hepatitis B vaccination completion: Letter in response to: Day et al. (in press)
by: Higgs, Peter, et al.
Published: (2016)

Development of antiviral strategies for treatment of chronic hepatitis B
by: Seow, Heng Fong, et al.
Published: (2002)

Hepatitis C transmission and treatment as prevention - The role of the injecting network
by: Hellard, M., et al.
Published: (2015)

Barriers to receiving hepatitis c treatment for people who inject drugs myths and evidence
by: Higgs, Peter, et al.
Published: (2011)

Pretreatment lesions on magnetic resonance imaging in patients with hepatitis C virus infection diagnosed with hepatocellular carcinoma after initiating direct-acting antiviral therapy
by: Scott, Robert A., et al.
Published: (2018)

Inheritance (Family Provision) Act 1971 (Act 39)
by: Ali Mohamed, Ashgar Ali
Published: (2010)

Molecular epidemiology and antiviral resistance characterization of Hepatitis C virus circulating in Africa and Brazil
by: Adeboyejo, Kazeem Adeyinka
Published: (2020)

The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs
by: Aitken, C., et al.
Published: (2017)

Preventing hepatitis C virus transmission among young people in the justice system
by: Lenton, E., et al.
Published: (2013)

An antiviral composition.
by: Abu Bakar, Fatimah, et al.
Published: (2011)

Identification of usnic acid derivatives as new antiviral agents via virtual screening on dengue, influenza A and avian influenza A
by: Miah, Roney
Published: (2022)

Pharmacy-led hepatitis C treatment pathways to help ensure elimination
by: Gunn, J., et al.
Published: (2019)

Assessment Of Antiviral Usage, Barriers, And Strategies For Scaling Up Hepatitis C Treatment In Malaysia: A Mix Methodology Study
by: Chan, Huan Keat
Published: (2023)

The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs
by: Hellard, M., et al.
Published: (2014)

Circular antiviral RNA
by: Omar, Abdul Rahman, et al.
Published: (2012)

An antiviral to cure patients
by: Tang, Ashley
Published: (2021)

Does informing people who inject drugs of their hepatitis C status influence their injecting behavior? Analysis of the Networks II study
by: Aspinall, E., et al.
Published: (2014)

Pharmacies dispensing opioid substitution therapy also play a role in hepatitis C virus elimination
by: Gunn, J., et al.
Published: (2018)

Tingkat penggunaan ubat antiviral
by: Halid, Suzalina
Published: (2022)

A review with updated perspectives on the antiviral potentials of traditional medicinal plants and their prospects in antiviral therapy
by: Saifulazmi, Nur Fadlin, et al.
Published: (2022)

Rapid testing for hepatitis C does not infer current infection
by: Nguyen, V., et al.
Published: (2017)

A response to: Self-reported and actual hepatitis C virus status
by: O'Keefe, D., et al.
Published: (2014)

Antiviral peptides against dengue virus
by: Lee, Michelle Felicia *, et al.
Published: (2022)

Structure activity relationship of dendrimer microbicides with dual action antiviral activity
by: Tyssen, D., et al.
Published: (2010)

Hepatitis C Virus Phylogenetic Clustering Is Associated with the Social-Injecting Network in a Cohort of People Who Inject Drugs
by: Sacks-Davis, R., et al.
Published: (2012)

Antivirals for influenza: where now for clinical practice and pandemic preparedness?
by: Nguyen-Van-Tam, Jonathan S., et al.
Published: (2014)

Chemical constituents and antiviral study of Goniothalamus velutinus
by: Fasihuddin Badruddin,, Ahmad, et al.
Published: (2014)

Cytomegalovirus replication steps and the actions of antiviral drugs
by: Abdullah, Ashwaq Ahmed, et al.
Published: (2018)

Divorce reform and family mediation in England: an overview of the relevant provisions of the Family Law Act, 1996
by: Ibrahim, Norliah, et al.
Published: (2009)

Perinatal transmission of hepatitis B: the Australian experience [letter]
by: Thompson, Sandra
Published: (2009)

High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort Study
by: Sacks-Davis, R., et al.
Published: (2013)

Molecular Mechanisms of Antiviral Agents against Dengue Virus
by: Lee, Michelle Felicia, et al.
Published: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fqh03jpphlnk0m8kkh1m74djbf